Crystal deal toy celebrating the initial public offering on the Australian Securities Exchange (ASX) of Radiopharm Theranostics. The Sydney-based company develops radiopharmaceutical drugs and treatments for cancer.
(21ALJ553)
Crystal deal toy celebrating the initial public offering on the Australian Securities Exchange (ASX) of Radiopharm Theranostics. The Sydney-based company develops radiopharmaceutical drugs and treatments for cancer.
(21ALJ553)Lucite financial tombstone, with spinning plexi logo, commemorating debt financing for Click Therapeutics. A New York-based health tech company, Click provides software as prescription medical treatments for people with unmet medical needs.
(21AKL594)Custom deal toy commemorating the acquisition of medical device firm Oscor. The Florida-based company provides devices ranging from implantable cardiac pacing leads to diagnostic catheters.
(21AJH186)Lucite deal toy marking the acquisition of Prisym ID, a Massachusetts-based company specializing in labeling for clinical trials, medical devices, and pharmaceuticals. The acquirer, Loftware, is the largest global software firm focused on enterprise labeling and artwork management.
(22AKL039)Crystal deal tombstone marking the acquisition of Emotec, an Italian manufacturer of disposable medical devices.
(22LSS027)Lucite deal tombstone commemorating the sale of over-the-counter
(OTC brand Zegerid. Zegerid is a treatment for frequent heartburn. 22AJH015)Lucite deal toy celebrating a license option agreement between Ironwood Pharmaceuticals and COUR, a biotech firm. The agreement centers on COUR’s therapy for PBC, a rare autoimmune disease affecting the liver.
(22ALJ081)
